Cell Therapeutics pays $10.5M to settle kickback claims

Cell Therapeutics of Seattle has agreed to pay a $10.5 million fine to resolve claims that it paid doctors up to $1500 to attend lectures on prescribing Trisenox along with illegal kickbacks to high-volume prescribers of the drug. According to the federal suit, Cell Therapeutics pushed physicians to prescribe the therapy for unauthorized uses, resulting in "tens of thousands" of fraudulent Medicare claims.

- see this release on the settlement
- read the report from The Seattle Times

Related Articles:
Cell Therapeutics sells Trisenox. Report
Trisenox demonstrates survival benefits. Report
Cell Therapeutics spins off new protein tech company. Report

Suggested Articles

Silverback Therapeutics reeled in $85 million to advance its lead antibody-drug conjugate through the clinic and develop its earlier-stage pipeline.

The reported requirements suggest a company is unlikely to have the data needed to support an EUA before the election in six weeks.  

Blocking tau appears to be just as fruitless as clearing amyloid buildup when it comes to helping Alzheimer’s disease patients.